UK Spinouts Raised €1.8 Billion in Six Months — But First-Time Funding Collapsed 68%

UK university spinouts raised €1.8 billion (£1.56 billion) across 215 deals in the first half of 2026, yet first-time equity investment into those same companies fell 68.3%, from €176 million to €56 million. That is the central contradiction in three studies published in 2026 by Cambridge Innovation Capital, Parkwalk with Beauhurst, and White & Case. Britain is pulling in more capital than ever — but increasingly for businesses that have already proven themselves.

Where is the money actually going?

Greater Cambridge anchors the story. Early-stage businesses in the region have raised €10.8 billion (£9.1 billion) since 2015, according to analysis by Cambridge Innovation Capital published for the Innovate Cambridge Summit 2026.

The average equity raised per deal has grown fivefold over the decade, from €2.3 million (£2 million) in 2015 to €11 million (£10 million) in 2025. Greater Cambridge's life sciences and DeepTech companies attracted more funding per deal on average in 2025 than counterparts in London, Greater Oxford and Greater Manchester.

Dr Michael Anstey, Partner at Cambridge Innovation Capital and board member of Innovate Cambridge, said: "A fivefold increase in average deal size over ten years shows how far Cambridge's innovation economy has matured. Investors are backing Cambridge companies with larger rounds because there is now a proven route from world-class research to businesses that can scale globally."

The proof points are concrete. Battery technology company Nyobolt raised €26.3 million in April 2025 and reached a $1 billion valuation in 2026. AI materials discovery startup CuspAI secured €393.2 million in July 2026 at a €2.2 billion valuation, launching an AI Materials Foundry with NVIDIA. DefenceTech company Cambridge Aerospace raised €259.7 million in August 2026 at a €2.94 billion valuation.

The spinout half-year total was the second-highest recorded in the past decade, up 38.2% on H2 2025. Four companies alone — Quantum Motion, Oxford Quantum Circuits, Fractile and CellCentric — accounted for €846 million (£709 million), with Oxford Quantum Circuits taking the period's largest round at €301 million (£260 million). In plain terms: a handful of large quantum and biotech deals is doing much of the work behind the headline figure.

Why is defence suddenly attractive to investors?

White & Case surveyed 250 senior decision-makers in the UK defence and military sector between 17 and 24 September 2026. It found 97% of UK defence companies and DefenceTech startups expect to seek significant external funding over the next 12 months.

The financing preferences split three ways:

• 49% intend to seek equity financing
• 47% plan to pursue debt financing
• 39% will apply for government grants

Equity matters most to the youngest companies: 59% of DefenceTech startups are considering it, against 49% of established defence firms. Many younger businesses have yet to generate significant revenue, which makes traditional debt difficult to obtain. Among companies seeking equity, 37% named government-backed investors as the most attractive source, ahead of corporate venture investors, strategic corporate investors and private equity firms.

Daniel Turgel, Partner and Co-head of White & Case's Global Technology Industry Group, said: "For the most promising businesses, there is no lack of equity financing. A wall of private capital is looking for a home in defence technology as previous investment restrictions are relaxed and investors rush to gain exposure to a highly attractive sector, with long-term structural growth tailwinds that extend beyond current conflicts and even defence itself."

Rising military spending, government efforts to build domestic technological capability and dual-use applications underpin the interest. DefenceTech, in short, is joining FinTech and life sciences as a pillar of UK startup investment.

What happened to first-time funding?

Here the picture darkens. First-time equity investment into UK university spinouts dropped from €176 million (£148 million) in H1 2025 to €56 million (£47 million) in H1 2026 — a fall of 68.3%. The number of first-time deals slipped from 47 to 44, far below the peak of 73 in H1 2021.

Later-stage investment moved the opposite way: €907 million (£760 million) in H1 2026, the highest half-year level since 2021 and a 165% year-on-year increase. Average deal sizes across the spinout ecosystem have more than doubled in a decade, from €4.2 million (£3.57 million) in H1 2016 to €8.6 million (£7.24 million) in H1 2026.

Moray Wright, CEO of Parkwalk, said: "British DeepTech is attracting capital at a scale we have rarely seen, and that is something to celebrate. But these figures carry a clear warning. First-time investment has fallen, and the companies vital to the future of the UK economy are struggling to raise their first round."

The takeaway is uncomfortable: capital is concentrating in established companies while the pipeline of new entrants narrows.

Who ultimately owns the value?

International investors participated in rounds accounting for 86.1% of total university spinout investment in H1 2026 — the highest share this decade. British investors remain the backbone of the ecosystem, joining 2,545 spinout deals since 2016, more than six times the 408 involving US investors.

But exits tell a different story. International buyers accounted for 75% of UK spinout acquisitions in H1 2026 and 68.3% since 2016. US buyers acquired 66 UK spinouts over the decade; British buyers acquired 57.

Geography compounds the imbalance. Nearly 80% of spinout investment since 2016 went to the South East, East of England and London. University of Oxford spinouts raised €6.4 billion (£5.39 billion); Cambridge raised €4.7 billion (£3.99 billion). Manchester spinouts attracted €232 million (£195 million), and Liverpool just €23.3 million (£19.6 million) — roughly one two-hundredth of Oxford's total.

The studies leave open who benefits when British innovation is financed globally and sold abroad. Whether the UK converts financial strength into durable European leadership will depend less on headline totals than on whether early-stage founders outside the golden triangle can actually raise a first round — and whether the companies that follow can be persuaded to stay British.